Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Ultragenyx Pharmaceutical Inc    RARE

ULTRAGENYX PHARMACEUTICAL INC

(RARE)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations
Sector news Bio Therapeutic Drugs
02/20GLOBAL MARKETS LIVE : Nissan, Lockheed Martin, UBS, Sainsbury...
02/12MARKET SNAPSHOT: Stocks Close At 2019 High On Tentative Deal To Avert Governm..
DJ
02/11Regeneron, Sanofi to Offer Praluent at Reduced U.S. List Price
DJ
02/11Sanofi and Regeneron cut list price of cholesterol drug by 60 percent
RE
02/06REGENERON PHARMACEUTICALS : 4Q Profit Rises
DJ
02/05U.S. jury orders Takeda to pay Bayer $155 million over haemophilia drug
RE
02/05Merck KGaA, GSK Enter Immuno-Oncology Deal Worth Up to $4.23 Billion -- Updat..
DJ
02/04GILEAD SCIENCES : Raises Dividend by 6 Cents a Share
DJ
02/04GILEAD SCIENCES : Struggling to Revamp Sales, Projects Another Annual Sales Decl..
DJ
02/04LILLY, INCYTE : Baricitinib Meets Primary Endpoint in Atopic Dermatitis Studies
DJ
01/30GLOBAL MARKETS LIVE : Alibaba, LVMH, Apple, Societe Generale…
01/30European Shares Rise as LVMH Boosts Luxury Stocks -- Market Talk
DJ
01/30SanBio's crash causes margin calls, drags down Japan's start-up market
RE
01/29VALE : Five People Arrested After Brazil's Vale Dam Collapse--2nd Update
DJ
01/29Swiss exports reach record high in 2018 despite strong franc
RE
01/29VALE : Five People Arrested After Brazil's Vale Dam Collapse--Update
DJ
01/28Ionis Says Partner Roche Enrolls First Patient in Huntington's Disease Study
DJ
01/24Roche's Genentech Names Alexander Hardy Chief Executive
DJ
01/18Samsung Bioepis biosimilar to Roche's Herceptin wins FDA nod
RE
01/08NEKTAR THERAPEUTICS : Shares Up Tuesday as Gilead Collaboration Announced -- Mar..
DJ
01/07MERCK AND : loses bid to revive $200 million Gilead verdict at U.S. high court
RE
01/07Sanofi, Regeneron Restructure Immuno-Oncology Agreement
DJ
01/05SOUTH KOREA'S CELLTRION AIMS TO SET : chairman
RE
01/03Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal
RE
01/03Bristol-Myers to buy Celgene for $74 billion in largest biopharma deal
RE
01/03Bristol-Myers' $74 billion Celgene buy has investors looking for next deal
RE
2018GILEAD SCIENCES : Agenus Agree to Develop, Commercialize Immuno-Oncology Therapi..
DJ
2018GILEAD SCIENCES : Scholar Rock to Develop Therapies for Fibrotic Diseases -- Upd..
DJ
2018GILEAD SCIENCES : Scholar Rock to Develop Therapies for Fibrotic Diseases
DJ
2018China's Junshi Biosciences raises $394 million after pricing IPO at bottom of..
RE
2018FDA Approves Herceptin Biosimilar Herzuma
DJ
2018Lilly, Incyte Get FDA Fast-Track Designation for Baricitinib in Systemic Lupu..
DJ
2018Almost half of S&P 500 stocks in a bear market
RE
2018ROCHE : Gilead Sciences snares Roche veteran O'Day as CEO
RE
2018LONZA : to Establish Biomanufacturing Base in China
DJ
2018Roche Pharmaceuticals Names New CEO as O'Day Leaves to Head Gilead -- Update
DJ
2018Roche Executive Named Gilead CEO -- 2nd Update
DJ
2018Gilead Taps Roche Veteran as New CEO -- WSJ
DJ
2018Roche Executive to Be Named Gilead CEO -- Update
DJ
2018Roche Executive to Be Named Gilead CEO
DJ
2018Moderna Declines in Market Debut -- WSJ
DJ
2018Moderna Declines in Public-Market Debut
DJ
2018GILEAD SCIENCES : U.K.'s NICE Recommends Gilead CAR-T Therapy, Reversing Earlier..
DJ
2018J&J unit to pay $360 million to U.S. to resolve charity kickback probe
RE
2018Amgen antibody shows promise in myeloma trial, gets FDA fast track
RE
2018FDA Approves Celltrion's Truxima As Biosimilar to Genentech's Rituxan
DJ
2018Oil, Tech Stocks Help Turn Around S&P Selloff
DJ
2018Ziopharm in Supply Agreement with Regeneron to Study Glioblastoma Treatment
DJ
2018Regeneron, Sanofi Get FDA Priority Review for Dupixent in Adolescents
DJ
2018REGENERON PHARMACEUTICALS : Posts Higher Profits Led By Treatment Advances
DJ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ULTRAGENYX PHARMACEUTICAL